Dipòsit Digital de Documents de la UAB
Publicación
Artículo científico (JournalArticle)
Design of Small Non-Peptidic Ligands That Alter Heteromerization between Cannabinoid CB and Serotonin 5HT Receptors
Activation of cannabinoid CB receptors (CBR) by agonists induces analgesia but also induces cognitive impairment through the heteromer formed between CBR and the serotonin 5HT receptor (5HTR). This side effect poses a serious drawback in the therapeutic use of cannabis for pain alleviation. Peptides designed from the transmembrane helices of CBR, which are predicted to bind 5HTR and alter the stability of the CBR-5HTR heteromer, have been shown to avert CBR agonist-induced cognitive impairment while preserving analgesia. Using these peptides as templates, we have now designed nonpeptidic small molecules that prevent CBR-5HTR heteromerization in bimolecular fluorescence complementation assays and the heteromerization-dependent allosteric modulations in cell signaling experiments. These results provide proof-of-principle for the design of optimized ligand-based disruptors of the CBR-5HTR heteromer, opening new perspectives for in vivo studies.
Proyecto:
Agencia Estatal de Investigación CEX2018-000792-M
,
Agencia Estatal de Investigación PID2022-140912OB-I00
,
Agencia Estatal de Investigación PID2020-113938RB-I00
,
Agencia Estatal de Investigación PID2023-146914OB-I00
,
Agència de Gestió d'Ajuts Universitaris i de Recerca 2021/SGR-00304
,
Agència de Gestió d'Ajuts Universitaris i de Recerca 2021/SGR-00230